Search results

• 2016

  Phase II Randomized Preoperative Window-of-Opportunity Study of the PI3K Inhibitor Pictilisib Plus Anastrozole Compared With Anastrozole Alone in Patients With Estrogen Receptor-Positive Breast Cancer

  Schmid, P., Pinder, S. E., Wheatley, D., Macaskill, J., Zammit, C., Hu, J., Price, R., Bundred, N., Hadad, S., Shia, A., Sarker, S. J., Lim, L., Gazinska, P., Woodman, N., Korbie, D., Trau, M., Mainwaring, P., Gendreau, S., Lackner, M. R., Derynck, M., & 6 othersWilson, T. R., Butler, H., Earl, G., Parker, P., Purushotham, A. & Thompson, A., 10 Jun 2016, In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 34, 17, p. 1987-1994

  Research output: Contribution to journal › Article › peer-review

  • Patient 100%
  • Estrogen Receptor Positive Breast Cancer 100%
  • Therapeutic Procedure 33%
  • Breast Cancer 33%
  • Suppression 33%
  78 Citations (Scopus)